Authors

• Xiangbin Pan (ORCID: https://orcid.org/0000-0002-2252-3393)
• Mengen Zhai
• Lai Wei (ORCID: https://orcid.org/0000-0003-4339-7055)
• Xiaoke Shang (ORCID: https://orcid.org/0000-0002-3263-5428)
• Yingqiang Guo (ORCID: https://orcid.org/0000-0002-3347-1680)
• Haibo Zhang (ORCID: https://orcid.org/0000-0001-6153-5568)
• Ping Jin (ORCID: https://orcid.org/0000-0003-2330-005X)
• Yu Mao (ORCID: https://orcid.org/0009-0002-6508-5458)
• Jian Yang (ORCID: https://orcid.org/0000-0003-4255-9622)
• Yang Liu (ORCID: https://orcid.org/0000-0002-7240-1546)

Institutions

• Union Hospital (HK)
• Capital Medical University (CN)
• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Sichuan University (CN)
• Fudan University (CN)
• West China Hospital of Sichuan University (CN)
• Beijing Anzhen Hospital (CN)
• Zhongshan Hospital (CN)
• Xijing Hospital (CN)
• Huazhong University of Science and Technology (CN)

Publication Details

Journal

Frontiers in Cardiovascular Medicine

Published

2024-08-30

DOI

https://doi.org/10.3389/fcvm.2024.1424116

Citations

2

Primary Topic

Cardiac Valve Diseases and Treatments

Type

article

Field-Weighted Citation Impact

0.80

Funders

• National Key Research and Development Program of China